COMMUNIQUÉS West-GlobeNewswire

-
Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis
21/07/2017 - 13:30 -
Sanofi et Regeneron obtiennent un avis favorable du CHMP pour Dupixent® (dupilumab) dans le traitement de la dermatite atopique modérée à sévère de l'adulte
21/07/2017 - 13:30 -
Novartis receives positive CHMP opinion for Rydapt® (midostaurin) for newly diagnosed FLT3-mutated acute myeloid leukemia (AML) and three types of advanced systemic mastocytosis (SM)
21/07/2017 - 13:19 -
uniQure Announces the Successful Development and Scale-up of Manufacturing Processes for Its Hemophilia B Gene Therapy Program
21/07/2017 - 13:00 -
LIDDS signs research agreement with major European pharma company
21/07/2017 - 10:00 -
Oriola Corporation's Half Year Financial Report January-June 2017
21/07/2017 - 07:30 -
Alligator Bioscience AB: Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy
21/07/2017 - 07:03 -
EUROPEAN COMMISSION APPROVES MARKETING AUTHORISATION FOR VELTASSA®
21/07/2017 - 06:58 -
Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging
20/07/2017 - 21:15 -
Sanofi : Disclosure of trading in own shares
20/07/2017 - 18:00 -
Sanofi : Déclaration des transactions sur actions propres
20/07/2017 - 18:00 -
PHARMAGEST: major acquisition in the hospital information systems sector.
20/07/2017 - 18:00 -
DarioHealth Announces Strategic Partnership with CCS Medical
24/07/2017 - 14:00 -
Auris Medical Completes Acquisition of AM-125 Assets
20/07/2017 - 14:00 -
ProMIS Neurosciences Announces CDN$3 Million Best-Efforts Private Placement
20/07/2017 - 13:30 -
LIDDS: LIDDS and Recipharm establish industrial manufacturing capabilities for a novel prostate cancer product
20/07/2017 - 10:00 -
Enzymatica AB: Continued sales growth and breakthrough order from STADA
20/07/2017 - 08:00 -
Basilea announces completion of the license agreement with Pfizer for antifungal Cresemba® for Europe, Russia, Turkey and Israel
20/07/2017 - 07:15 -
ABLYNX AND SANOFI ENTER INTO A STRATEGIC COLLABORATION TO DEVELOP NANOBODY PRODUCT CANDIDATES FOCUSED ON IMMUNE-MEDIATED INFLAMMATORY DISEASES
20/07/2017 - 07:00
Pages